GlobeNewswire

New Research Reveals Majority of Recruiters Ready for GDPR; Concerns Remain About Sourcing and Hiring Under New Guidelines

Share

Data from Lever Examines How Organizations are Preparing for GDPR Compliance Specific to Recruiting and Hiring

 

SAN FRANCISCO, March 27, 2018 (GLOBE NEWSWIRE) -- While nearly three quarters of organizations feel confident in their ability to achieve General Data Protection Regulation (GDPR) compliance for their recruiting efforts by the May 25th deadline, most still harbor concerns about how the new regulations will impact their hiring process, according to new research from Lever, the recruiting software for more than 1,500 leading companies around the world. Lever surveyed 500 professionals across the EU and US directly involved in preparing their organizations for GDPR compliance for recruiting.

According to the survey results, 70 percent of respondents believe they will be prepared for GDPR compliant recruiting by May 25th, but preparation doesn't come overnight, or in a silo. Nearly a third of respondents say they are investing significant time and resources into becoming GDPR compliant and 73 percent are working with external or internal legal counsel to prepare.

Despite this high level of preparedness, 61 percent of respondents are concerned about the impact of GDPR on their recruiting and hiring processes, including how they source potential candidates. Respondents were also either 'very concerned' or 'extremely concerned' about adhering to specific requirements included in the regulations, such as:

  • Maintaining full records of recruiting processing activities (52 percent)
  • Determining when to get consent from candidates (50 percent)
  • Determining how long to store a candidate's personal data before deleting it or obtaining consent (47 percent)
  • Selecting software vendors who will enter into GDPR compliant contracts and meet data security requirements (46 percent)

Regardless of these concerns, the overwhelming majority (90 percent) of respondents who are already engaged in sourcing will continue to do so under GDPR.

"The GDPR deadline is quickly approaching, but few are discussing the potential impact these regulations will have on how organizations source, recruit and hire their talent," said Mike Walsh, Director of Product Marketing of Lever. "We hope this research serves as a catalyst within organizations to begin discussing in detail how they will move forward with sourcing candidates under GDPR and the lengths they will go to protect candidate data. At Lever, we have spent significant time working on these issues on behalf of our clients and hope to continue to serve as a resource for recruiters worldwide."

Lever's research also revealed some organizations are unsure how to adhere to regulations related to candidate data. According to the GDPR, organizations must identify their own "lawful basis" for processing personal candidate data. For recruiting, the most common lawful bases are consent and legitimate interest, but it can be a grey area for many recruiters.

For example, respondents are split regarding when to collect consent from candidates. Only 40 percent of respondents will collect consent to contact for jobs they did not apply to, 37 percent will collect consent in order to email candidates they source and 25.5 percent will collect consent when they plan to keep data from candidates who were in their ATS before May 25th, 2018.

Another grey area the survey addressed was determining how long to store candidate data. While GDPR requires companies to only keep personal data for "no longer than is necessary for the purposes for which the personal data are processed," the data showed great variation in how organizations are interpreting this obligation. Some companies will delete candidate data as soon as the job they were tied to closes (23 percent), while others plan to retain candidate data for a year or more (23 percent).

The full research report can be downloaded at this link.

Methodology
From March 2 - 8, 2018, Lever surveyed 500 professionals across the EU and US who are directly involved in preparing their organizations for GDPR compliance for recruiting.

About Lever
Built from the conviction that recruiting is the responsibility of everyone at the company, Lever's applicant tracking and sourcing technology draws the entire team together to source, nurture, interview, and hire top talent through effortless collaboration. Lever has been intentionally designed with integrated ATS and CRM functionality, and features a modern interface that helps employers develop stronger candidate relationships in fewer clicks. 

Lever was founded in 2012 in San Francisco. The company has raised more than $73 million in funding from Adams Street Partners, Scale Venture Partners, Matrix Partners, Y Combinator, Redpoint Ventures, and Correlation Ventures among others. Lever supports the hiring needs of over 1,500 companies around the globe including the teams at Netflix, Hot Topic, KPMG New Zealand, and Cirque du Soleil. With an overall gender ratio of 50:50, Lever is also fiercely committed to building a team culture that celebrates diversity and inclusion. For more information, visit https://www.lever.co.

MEDIA CONTACT:
Ashley Cohen
Traeger Communications
acohen@traegercommunications.com
303-522-0783




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lever, Inc. via Globenewswire

About GlobeNewswire

GlobeNewswire



Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Karolinska Development delays publication of its Annual Report for 2018 and changes date for the Annual General Meeting26.4.2019 08:00:00 CESTPress release

STOCKHOLM, SWEDEN - 26 April 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that The Board of Directors has decided to delay the publication of its Annual Report for 2018. Karolinska Development has changed the date for the Annual General Meeting to June 26, 2019. The date for publication of the Annual Report for 2018 has been changed from April 26 to April 30, 2019. Karolinska Development has changed the date for the Annual General Meeting from June 4 to June 26, 2019. Notice to the Annual General Meeting will be published in a separate press release. For more information, please contact: Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, CFO, Karolinska Development AB Phone: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TO THE EDITORS About Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investmen

Karolinska Development senarelägger publicering av årsredovisningen för 2018 och meddelar nytt datum för årsstämma26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 26 april 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att styrelsen har beslutat att senarelägga publiceringen av årsredovisningen för 2018. Karolinska Development har ändrat datum för årsstämman till den 26 juni 2019. Publiceringen av årsredovisningen för 2018 flyttas från den 26 april till den 30 april 2019. Karolinska Development har ändrat datum för årsstämman från den 4 juni till den 26 juni 2019. Kallelse till årsstämman kommer att publiceras senare i ett separat pressmeddelande. För ytterligare information, vänligen kontakta: Viktor Drvota, vd, Karolinska Development AB Tel: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, finanschef, Karolinska Development AB Tel: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TILL REDAKTÖRERNA Om Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) är ett nordiskt investmentbolag inom life science. Bolaget fokuserar p

Karolinska Developments portföljbolag Aprea Therapeutics har fått särläkemedelsstatus och snabbspårstatus från FDA för APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 16 april 2019. Karolinska Development AB meddelar idag att portföljbolaget Aprea Therapeutics har av FDA fått särläkemedelsstatus för APR-246 för behandling av patienter med TP53-muterad myelodysplastiskt syndrom (MDS). Dessutom ger FDA bolaget snabbspårstatus (Fast Track Designation), för APR-246 för behandling av MDS. Amerikanska läkemedelsverket, FDA, ger särläkemedelsstatus till läkemedelskandidater för att snabba på utvärderingen och utvecklingen av säkra och effektiva behandlingar av ovanliga sjukdomar. Särläkemedelsstatus ger företag både regulatoriska och kommersiella incitament genom att läkemedlet får marknadsexklusivitet på den amerikanska marknaden i sju år efter marknadsgodkännande samtidigt som företaget får stöd från FDA när det gäller designen av kliniska prövningar, skatteförmåner för kostnader kopplade till kliniska prövningar och avgiftsbefrielse från FDA. FDA:s snabbspår underlättar utvecklingen av läkemedel som är avsedda för att behandla allva

Karolinska Development's portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-24616.4.2019 12:46:00 CESTPress release

STOCKHOLM, April 16, 2019. Karolinska Development's portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes (MDS) having a TP53 mutation. In addition, FDA has also granted Fast Track Designation to APR-246 for treatment of MDS. Orphan Drug Designation is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. after product approval, FDA assistance in clinical trial design, tax credits related to clinical trial expenses, and an exemption from FDA user fees. The FDA's Fast Track program facilitates the development of drugs intended to treat serious conditions and that have the potential to addre

Bergman & Beving AB: Bergman & Beving förvärvar KGC10.4.2019 14:00:00 CESTPressmeddelande

Pressmeddelande Bergman & Beving förvärvar KGC Bergman & Beving har idag tecknat avtal om förvärv av samtliga aktier i KGC Verktyg & Maskiner AB. KGC, med säte i Älvsjö, har i mer än 60 år utvecklat och levererat kvalitetsverktyg och tillbehör för murning och plattsättning i det egna varumärket KGC. Bolaget omsätter cirka 80 MSEK per år, och har 24 anställda. "KGC är ett ledande varumärke med högt anseende hos murare och plattsättare och har en mycket stark ställning på den svenska marknaden", säger Pontus Boman, VD och koncernchef. Tillträde beräknas ske den 1 maj 2019 och förvärvet bedöms ha en marginellt positiv påverkan på Bergman & Bevings resultat per aktie under innevarande räkenskapsår. Stockholm den 10 april 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Pontus Boman, VD & Koncernchef, telefon 010-454 77 00 Peter Schön, CFO, telefon 070-339 89 99 Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 10 april 201

Bergman & Beving AB: Bergman & Beving acquires KGC10.4.2019 14:00:00 CESTPress release

Press release Bergman & Beving acquires KGC Bergman & Beving has today signed an agreement to acquire all shares in KGC Verktyg & Maskiner AB. KGC, based in Älvsjö, has for more than 60 years developed and delivered quality tools and accessories for bricklayers and tilers in its own brand KGC. The business has a turnover of approximately SEK 80 million per year, and has 24 employees. "KGC is a leading brand with high reputation among bricklayers and tilers and has a very strong position in the Swedish market," says Pontus Boman, President and CEO. The closing is taking effect on 1 May 2019 and the acquisition is expected to have a marginal positive impact on Bergman & Beving's earnings per share during the current fiscal year. Stockholm, 10 April 2019 Bergman & Beving AB (publ) For further information, please contact: Pontus Boman, President & CEO, Tel: +46 10 454 77 00 Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the cont

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom